Nicholas DeVito
6PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 07, 2026
Addressing Common Medications That Influence Immunotherapy Response in Solid Tumors.Nicholas DeVito, Erica Gray, Daniel Schrum
|Feb 19, 2025
GLI2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating WNT and Prostaglandin Signaling.Nicholas C DeVito, Y-Van Nguyen, Michael Sturdivant
|May 10, 2024
A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression.Michael P Plebanek, Yue Xue, Y-Van Nguyen
|Apr 15, 2024
Gli2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating Wnt Ligand and Prostaglandin Signaling.Nicholas C DeVito, Y-Van Nguyen, Michael Sturdivant
|Nov 23, 2022
Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti-PD-1 immunotherapy.Balamayooran Theivanthiran, Nagendra Yarla, Tarek Haykal
|Oct 13, 2021
Overcoming Immunotherapy Resistance by Targeting the Tumor-Intrinsic NLRP3-HSP70 Signaling Axis.Balamayooran Theivanthiran, Tarek Haykal, Linda Cao
Pageof 1
Frequent Collaborators
5 joint publications
Brent A Hanks
4 joint publications
Georgia M Beasley
3 joint publications
Alisha Holtzhausen
3 joint publications
Balamayooran Theivanthiran
3 joint publications
Y-Van Nguyen
2 joint publications
Tarek Haykal
2 joint publications
Michael P Plebanek
1 joint publications
Linda Cao
1 joint publications
Michelle Ferreira
1 joint publications
Rami Al-Rohil
